NCT02101853-D2
Dataset Information
Dataset ID: NCT02101853-D2
PubMed ID (PMID):
Publication Title:
Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Description of Dataset:
NCT02101853-D2: There are a total of 2 datasets associated with the PubMed 33651090: NCT02101853-D1 through NCT02101853-D2. This dataset, NCT02101853-D2, is required for providing specific incidence of adverse events in interest. Adverse events that occurred with a grade of 3 or above at a frequency of 5% or greater in at least one course for the patients in the primary analysis are included. There are multiple rows per patient depending on the adverse events in interest that a patient had experienced. Each row corresponds to a single AE event.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02101853 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®